Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | 0 | 132 | 536 | 8,766 |
| Gross Profit | N/A | N/A | 132 | 536 | 8,766 |
| Operating Expenses | 49,051 | 43,331 | 38,260 | 30,851 | 26,135 |
| Operating Income | -49,051 | -43,331 | -38,128 | -30,315 | -17,369 |
| Other Income | 7,614 | 7,075 | 391 | -883 | -2,695 |
| Pre-tax Income | -41,437 | -36,256 | -37,737 | -31,198 | -20,064 |
| Income Tax | 290 | 1,139 | -587 | -40 | -394 |
| Net Income Continuous | -41,727 | -37,395 | -37,150 | -31,158 | -19,670 |
| Net Income | $-41,727 | $-37,395 | $-37,150 | $-31,158 | $-19,670 |
| EPS Basic Total Ops | -0.63 | -0.59 | -0.57 | -0.55 | -0.35 |
| EPS Basic Continuous Ops | -0.63 | -0.59 | -0.57 | -0.55 | -0.36 |
| EPS Diluted Total Ops | -0.63 | -0.59 | -0.57 | -0.55 | -0.35 |
| EPS Diluted Continuous Ops | -0.63 | -0.59 | -0.57 | -0.55 | -0.36 |
| EBITDA(a) | $-48,697 | $-42,816 | $-37,770 | $-29,940 | $-16,993 |